Vasa Therapeutics is a privately held, preclinical-stage encinitas, CA-based biopharmaceutical company.

Vasa Therapeutics

Jaroslaw Leszczyszyn

Mark Herbert

Vasa Therapeutics is a San Diego-based, private biotechnology company committed to the discovery and development of therapeutics that target pathophysiology of cardiovascular aging.
Vasa Therapeutics has three active preclinical programs: 

1. VS-041 is the first personalized medicine-based treatment of HFpEF.  VS-041 shows robust reduction of cardiac fibrosis in a preclinical HFpEF model and inhibits release of signaling collagen fragments, such as PRO-C6, that mediate fibroinflammatory responses and are biomarkers of worse outcomes in HFpEF patients. Phase 1 clinical trial of VS-041 is planned for 2024.

2. Long acting apelin peptide analogs for combination treatment with incretins in obesity patients at risk for skeletal muscle loss or cardiovascular disease. As a monotherapy, long acting apelin agonists could also be beneficial in muscle atrophy, heart failure, chronic kidney disease, and peripheral artery disease.

3. A best-in-class inhibitor of CamKIId for heart failure and life-threatening arrhythmias.

Biotechnology Companies

Medical Organizations

Pharmaceutical Companies

Christopher J. Larson

Orphinic Scientific

Biotech platform for innovative solutions

SeedFolio

NuFund Venture Group

San Diego

City in San Diego County, California, United States; second-largest city in California

United States of America

Country primarily located in North America

California

San Diego County

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Pharmaceutical Preparation Manufacturing

Pharmaceutical and Medicine Manufacturing

Chemical Manufacturing

Manufacturing

Health Care and Social Assistance

Health Care and Social Assistance, Health

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Pharmaceutical Preparations

Drugs

Chemicals And Allied Products

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Offices And Clinics Of Other Health Practitioners

Health Services

Preclinical-stage biopharmaceutical company

Biotechnology

Vasa Therapeutics Funding & Investors

Total Amount Raised: $8,300,000

Vasa Therapeutics Funding Rounds

Seed Investors

💸 Investors

💻 Job Types

📚 Popular Blog Posts